RESOURCES

The following resources are
provided to assist you in helping
patients manage their diabetic eye disease

For You and
Your Staff

To help you identify DR and know when to timely refer patients.

Diabetic Retinopathy (DR) Patient
Identification and Referral Guide

Diabetic Retinopathy Patient Identification and Referral Guide PDF download.

A guide that describes the clinical features of DR at various stages and includes the current referral guidelines from the American Optometric Association (AOA). This tool will help facilitate early detection and timely referral to a retina specialist when appropriate.

Diabetic Retinopathy (DR) Quick
Reference Guide

Diabetic Retinopathy (DR) Quick Reference Guide PDF download

A handy reference guide to help identify the stages of DR and presence of DME. Includes an overview of the Early Treatment Diabetic Retinopathy Study-Diabetic Retinopathy Severity Scale (ETDRS-DRSS) with corresponding images and labeled descriptions.


Patient Education Resources

To help patients and their families and caregivers understand diabetic eye disease.

Amsler Grid

Amsler Grid PDF download

A printable Amsler Grid with patient-friendly instructions on how to use the tool to monitor vision. The Amsler Grid is a remote vision monitoring tool to help patients monitor changes in vision at home in between treatments.

DME Patient Brochure: English

DME Patient Brochure - English PDF download

A patient education brochure that explains what Diabetic Macular Edema (DME) is, who it affects, how it can affect vision, and treatment with EYLEA.

DME Patient Brochure: Spanish

DME Patient Brochure - Spanish

A Spanish-language patient education brochure that explains what Diabetic Macular Edema (DME) is, who it affects, how it can affect vision, and treatment with EYLEA.

Doctor Discussion Guide

Doctor Discussion Guide

A guide to help ask questions during your first eye care appointment.

DR In-Office Patient Education Slider

A tool for optometrist offices to help patients understand the different stages of DR and the progression of anatomic changes.

DR In-Office Poster: English

Diabetic RetinopathyIn-Office Poster PDF download

A poster for optometrists' offices to help patients understand the different stages of DR, as well as the importance of caring for their eyes by talking to their eye doctor and receiving a timely referral to a retina specialist when appropriate.

DR In-Office Poster: Spanish

A Spanish-language poster for optometrists' offices to help patients understand the different stages of DR, as well as the importance of caring for their eyes by talking to their eye doctor and receiving a timely referral to a retina specialist when appropriate.

DR Patient Brochure: English

Diabetic RetinopathyIn-Office Poster PDF download

A patient education brochure that explains what DR is, who it affects, how it can affect vision and progress, and treatment with EYLEA.

DR Patient Brochure: Spanish

A Spanish-language patient education brochure that explains what DR is, who it affects, how it can affect vision and progress, and treatment with EYLEA.

Low Vision Tip Sheet

A document that provides patients with tips and suggestions to help in their daily lives when living with low vision.

Patient Tearsheet: English

Diabetic Retinopathy (DR) Patient Tearsheet PDF download

A take-home tearsheet for patients that reinforces the importance of early disease detection, timely treatment, and follow-up care.

Patient Tearsheet: Spanish

Diabetic Retinopathy (DR) Patient Tearsheet PDF download

A Spanish-language take-home tearsheet for patients that reinforces the importance of early disease detection, timely treatment, and follow-up care.

EYLEA Prescribing Information

EYLEA USPI August 2019 PDF download

A detailed description of the indications, dosage and administration, safety, and efficacy of EYLEA.

See More Important Safety Information and Indications
  • CONTRAINDICATIONS: EYLEA® (aflibercept) Injection is contraindicated in patients with ocular or periocular infections, active intraocular inflammation, or known hypersensitivity to aflibercept or to any of the excipients in EYLEA.
Important Safety Information and Indications INDICATIONS

EYLEA® (aflibercept) Injection 2 mg (0.05 mL) is indicated for the treatment of patients with Neovascular (Wet) Age-related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), and Diabetic Retinopathy (DR).

Please see the full Prescribing Information for EYLEA.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

The information provided in this site is intended for U.S. Doctors of Optometry.